A randomised trial comparing 5-FU with 5-FU plus cisplatin in advanced pancreatic carcinoma. (Q44104072)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12181240%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

title

A randomised trial comparing 5-FU with 5-FU plus cisplatin in advanced pancreatic carcinoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12181240%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12181240%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

Marc Ychou

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12181240%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

author name string

M Ducreux

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12181240%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

P Rougier

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12181240%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

J-Y Douillard

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12181240%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

J-F Seitz

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12181240%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

R Bugat

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12181240%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

J-F Bosset

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12181240%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

Y Merouche

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12181240%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

J-L Raoul

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12181240%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

A Adenis

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12181240%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

F Berthault-Cvitkovic

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12181240%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

M Luboinski

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12181240%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

Groupe Digestif of the Fédération Nationale des Centres de Lutte Contre le Cancer Digestif

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12181240%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

language of work or name

1 reference

1 August 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12181240%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12181240%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

volume

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12181240%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12181240%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

page(s)

1185-1191

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12181240%20AND%20SRC:MED&resulttype=core&format=json

Estimates of the worldwide mortality from 25 cancers in 1990.

12 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDF197

Pancreaticoduodenectomy for cancer of the head of the pancreas. 201 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDF197

The value of minimal access surgery in the staging of patients with potentially resectable peripancreatic malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDF197

Chemotherapy prolongs survival in inoperable pancreatic carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDF197

Chemotherapy improves survival and quality of life in advanced pancreatic and biliary cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDF197

A comparison of three chemotherapeutic regimens in the treatment of advanced pancreatic and gastric carcinoma. Fluorouracil vs fluorouracil and doxorubicin vs fluorouracil, doxorubicin, and mitomycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDF197

Phase II study of cisplatin and 120-hour continuous infusion of 5-fluorouracil in patients with advanced pancreatic adenocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDF197

Measuring the quality of life of cancer patients: a concise QL-index for use by physicians.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDF197

A phase III trial on the therapy of advanced pancreatic carcinoma. Evaluations of the Mallinson regimen and combined 5-fluorouracil, doxorubicin, and cisplatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDF197

A phase II study in advanced gastro-esophageal cancer using epirubicin and cisplatin in combination with continuous infusion 5-fluorouracil (ECF).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDF197

Phase II trial of 5-fluorouracil, leucovorin and cisplatin for treatment of advanced pancreatic adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDF197

Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDF197